Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|
| Dir | | 474.0K | $234.32M | -18,410 |
| Dir | Taub Rebecca | 455.8K | $225.34M | -240 |
| Dir | | 357.8K | $176.89M | - |
| Dir | | 211.7K | $104.65M | -24,800 |
| ? | | 198.2K | $98.00M | - |
Transactions
50 transactions · page 9
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|
| 2024-04-02 | BATE KENNETH | Director | Sale+OE | 31,272 | $253.23 | $7,918,923.62 | -35.2% | → |
| 2024-04-01 | Levy Richard S | Director | Sale+OE | 11,000 | $257.48 | $2,832,334.60 | -13.0% | → |
| 2024-04-01 | Daly James M | Director | Sale+OE | 21,577 | $257.24 | $5,550,543.75 | -32.0% | → |
| 2023-12-15 | Waltermire Robert E. | Senior VP, Chief Pharma Dev. | Sale+OE | 4,000 | $235.50 | $942,000.00 | -14.0% | → |
| 2023-12-14 | BAKER BROS. ADVISORS LP | Director | Buy | 75,589 | $220.75 | $16,685,901.10 | +0.6% | → |